We previously reported that SAA performs well as a biomarker of endoscopic mucosal activity in clinical remissive (Rachmileswitz clinical activity index of 4 or less) ulcerative colitis (UC) [7]. This evidence concerns the gene SAA2 and ulcerative colitis.